CSL Bulk Human Coagulation Factor VIII 500 IU (100 IU/mL) / von Willebrand factor 1200 IU powder for injection vial

国家: 澳大利亚

语言: 英文

来源: Department of Health (Therapeutic Goods Administration)

现在购买

公众评估报告 公众评估报告 (PAR)
26-11-2017

有效成分:

Von willebrand factor, Quantity: 1200 IU; Factor VIII, Quantity: 500 IU

可用日期:

CSL Behring Australia Pty Ltd

INN(国际名称):

Factor VIII,Von willebrand factor

药物剂型:

Injection, powder for

组成:

Excipient Ingredients: sucrose; trometamol; sodium chloride; Albumin; sodium citrate dihydrate; calcium chloride dihydrate

给药途径:

Intravenous

疗效迹象:

von Willebrand disease (VWD) - Treatment of haemorrhage or prevention and treatment of surgical bleeding in patients with VWD, when desmopressin (DDAVP) treatment alone is ineffective or contraindicated. Haemophilia A (congenital FVIII deficiency) - Prophylaxis and treatment of bleeding in patients with haemophilia A.

產品總結:

Visual Identification: A white or pale yellow, hygroscopic powder or friable solid; Container Type: Vial; Container Life Time: 3 Years; Container Temperature: Store below 25 degrees Celsius

授权状态:

Licence status A

授权日期:

2013-09-02